Status:
COMPLETED
CoVid-19 - Infection and Antibody Formation in the Viennese Population
Lead Sponsor:
Ludwig Boltzmann Institute for Lung Health
Conditions:
Virus Diseases
COVID-19
Eligibility:
All Genders
6-85 years
Brief Summary
Summary of the study Study population: A representative sample of the Viennese population stratified by age and gender (data from the Vienna Health Study LEAD) Potential output and analysis: * Ext...
Detailed Description
Both international (WHO; (1) and national are calling for increased testing for the SARS-CoV-2 virus; at present it is completely unclear how many people will actually become infected with the Covid-1...
Eligibility Criteria
Inclusion
- all participants of the Austrian LEAD study will be invited (www.leadstudy.at) -
Exclusion
- pregnancy, failure due to language
- \-
Key Trial Info
Start Date :
April 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 27 2020
Estimated Enrollment :
12419 Patients enrolled
Trial Details
Trial ID
NCT04346264
Start Date
April 27 2020
End Date
May 27 2020
Last Update
May 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The LEAD Study Center
Vienna, Austria, 1140